HER-2 antibody conjugated gold nano rod particles for in vivo photothermal therapy

2008 8th IEEE Conference on Nanotechnology, IEEE-NANO

Volumn , Issue , 2008, Pages 882-885

  Ding, Ann Ann ^a   Chen, Ying Yi ^b   Churng Wang, Ren Chris ^b   Li, Pai Chi ^c   Shieh, Dar Bin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; ANTIBODIES; ASPECT RATIO; DIAGNOSIS; ELECTROMAGNETIC WAVES; ELECTRON OPTICS; INFRARED DEVICES; LASERS; NANORODS; NANOSTRUCTURES; NANOTECHNOLOGY; PRESSURE DROP; RESONANCE; SURFACE PLASMON RESONANCE; TUMORS;

BIO COMPATIBILITIES; CANCER CELLS; CANCER.; ELECTROMAGNETIC RADIATIONS; HIGH TEMPERATURES; HUMAN TISSUES; IN VITRO; IN VIVO MODELS; IN-VIVO; LASER INDUCED; LASER LIGHTS; LASER WAVELENGTHS; LOCAL TEMPERATURES; MOLECULAR IMAGING; MULTIPLE TARGETS; NANOSCALE PRECISIONS; NIR LASERS; NIR RANGES; OPTICAL WINDOWS; PHOTOTHERMAL THERAPIES; PLASMONIC RESONANCES; PRECISE CONTROLS; SIDE EFFECTS; SINGLE PLATFORMS; TREATMENT GROUPS; TUMOR CELLS;

HYPERTHERMIA THERAPY;

EID: 55349120859     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/NANO.2008.264     Document Type: Conference Paper

References (4)

1. A N Bashkatov, E A Genina, V I Kochubey and V V Tuchin, "Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000nm," J. Phys. D: Appl. Phys.vol. 38, pp 2543-2555, April 2005.
2. Funda Meric-Bernstam and Mien-Chie Hung, "Advances in Targeting Human Epidermal Growth Factor Receptor-2 Signaling for Cancer Therapy," Clin Cancer Res, vol. 12, pp.6326-6330. November 2006.
3. C. H. Chou, C. D. Chen and C. R. C. Wang, "Highly Efficient, Wavelength-Tunable, Gold Nanoparticle Based Photothermal Nanoconvertors," J. Phys. Chem. B, vol. 109, pp. 11135-11138, March 2005
4. P.M.Ravdin, G.C. Chamness, "The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers," Gene.vol.159, pp. 19-27 June 1995.